Table III.
Comparison of demographic and immune parameters between rheumatoid arthritis follow up patients classified on the basis of DAS28-CRP(3) into sustained remission and relapse
| Demographic and immune variables# | Sustained remission (n=30) | Relapse (n=13) |
|---|---|---|
| DAS28-CRP(3) groups | ≤2.6 | >2.6 |
| Age (yr) | 46.4±10.56 | 48.54±5.3 |
| Gender (male/female) | 4/26 | 2/11 |
| Duration of illness (months) | 54 (7-240) | 60 (24-120) |
| Neutrophil to lymphocyte ratio | 2.21 (1.09-4.42) | 2.75 (1.4-6.65) |
| ≤2 | 14 | 2 |
| >2-≤4 | 14 | 8 |
| >4 | 2 | 3 |
| CD3 (cells/µl) | 708 (293-2130) | 710 (176-1313) |
| CD4 (cells/µl) | 409.5 (175.77-1420.98) | 473.79 (142.65-847.12) |
| FOXP3 (cells/µl) | 0.248 (0.00-9.26) | 0.398 (0.00-7.4) |
| CD19 (cells/µl) | 145.8±74.84 | 164.62±87.65 |
| FOX P3:CD4 ratio | 0.001 (0.00-0.05) | 0.001 (0.00-0.016) |
| CD3:CD19 ratio | 4.84 (1.61-54.4) | 4.77 (2.19-16.74) |
| IL-6 (pg/ml) | ||
| Below detection limit (≤2.2) | 20 | 10 |
| Above detection limit (>2.2) | 10 | 3 |
| IL-10 (pg/ml) | ||
| Below detection limit (≤2) | 28 | 11 |
| Above detection limit (>2) | 2 | 2 |
#Continuous variables represented as mean±SD for normal data and median (range) data for those without normal distribution. Counts are given for categorical variables